🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
0.7545
-0.0552 (-6.82%)
Nov 20, 2026, 1:59 PM EST - Market open

Sonoma Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
4.612.45.373.133.827.4
Cash & Short-Term Investments
4.612.45.373.133.827.4
Cash Growth
51.86%-55.36%71.80%-18.12%-48.35%75.26%
Accounts Receivable
3.582.532.232.92.572.41
Other Receivables
-0.090.210.260.240.22
Receivables
3.582.612.443.162.812.63
Inventory
3.513.652.922.722.862.66
Prepaid Expenses
3.643.441.923.544.313.75
Total Current Assets
15.3412.112.6512.5513.816.43
Property, Plant & Equipment
0.820.910.310.650.910.88
Long-Term Deferred Tax Assets
0.880.880.591.150.950.83
Other Long-Term Assets
0.060.060.150.40.580.71
Total Assets
17.113.9613.6914.7416.2318.85

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1.551.920.950.610.841.64
Accrued Expenses
2.61.721.741.421.461.06
Short-Term Debt
0.060.220.220.320.430.69
Current Portion of Long-Term Debt
-----0.12
Current Portion of Leases
0.160.150.060.20.260.25
Current Unearned Revenue
0.050.280.640.480.161.28
Other Current Liabilities
-0.530.490.690.570.78
Total Current Liabilities
4.424.834.13.723.725.82
Long-Term Leases
0.380.470.030.090.160.31
Long-Term Unearned Revenue
--0.020.090.140.18
Other Long-Term Liabilities
5.695.565.144.714.243.84
Total Liabilities
10.4910.879.288.68.2510.15

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
----0.010
Additional Paid-In Capital
211.32207.32206.59203.21200.9197.37
Retained Earnings
-201.38-200.98-197.81-194.35-189.51-184.36
Comprehensive Income & Other
-3.33-3.24-4.38-2.72-3.42-4.31
Shareholders' Equity
6.613.14.416.147.988.7
Total Liabilities & Equity
17.113.9613.6914.7416.2318.85

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
0.60.840.310.610.851.37
Net Cash (Debt)
4.011.565.072.522.976.03
Net Cash Growth
60.28%-69.28%101.15%-15.18%-50.72%290.23%
Net Cash Per Share
1.310.924.085.5417.5145.45
Filing Date Shares Outstanding
5.064.791.640.940.250.16
Total Common Shares Outstanding
5.061.81.630.780.250.16
Working Capital
10.937.278.558.8310.0810.61
Book Value Per Share
1.311.722.707.8632.3456.09
Tangible Book Value
6.613.14.416.147.988.7
Tangible Book Value Per Share
1.311.722.707.8632.3456.09
Machinery
-2.231.812.141.951.53
Leasehold Improvements
-0.560.490.610.550.5
SEC Filings: 10-K · 10-Q